Aurobindo puts its injectables business on the block, again

Aurobindo Pharma promoters have begun the process of selling a majority stake in its injectables business, Eugia Pharma Specialities, after negotiations with potential suitors failed to meet valuation expectations. The promoters have hired investment bank Moelis to manage the sale.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MiuHhlz
via IFTTT